Navigation Links
The Quantum Group Announces Strategic Technology Alliance
Date:2/26/2008

Partners with Net.Orange to provide industry-wide solution

WELLINGTON, Fla., Feb. 26 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP, QGP.WSA, QGP.WSB) (http://www.QuantumMD.com) today announced a multi-dimensional, six year alliance established by Quantum wholly-owned subsidiary Quantum Medical Technologies, Inc. with Texas-based Net.Orange, Inc., inventor of the revolutionary cOS(TM) (Clinical Operating System) and many general and therapeutic-specific technology solutions.

The partnership with Net.Orange will bring tested and proven technology processes to the healthcare industry, beginning with the Quantum network of healthcare providers, patients and payers. Additionally, with this new development, the Company further capitalizes on the technology-based provisional business process patents it filed earlier this year.

Pete Martinez, Senior Vice President and Chief Technology and Innovations Officer of The Quantum Group commented, "This is an unprecedented alliance in healthcare. By combining an existing network of more than 1,800 providers with the state-of-the-art business processes, web-based technologies and tools, we will provide real-time value to healthcare services and adoption of the technology. Providers will no longer struggle to identify which technology solutions are right for them, to integrate complex systems in their office or pay for unique pieces of an endless puzzle. We will integrate solutions seamlessly into one patient-centric web-based system. We are bringing the business of healthcare into the 21st century."

Dr. Vasu Rangadass, CEO of Net.Orange stated, "This collaboration is a solution provider's dream. Our relationship with Quantum provides an instant and large base of users anxious for the quality of healthcare improvements we provide. Pairing our innovations in usability, connectivity, and process management with Quantum's provider
'/>"/>

SOURCE The Quantum Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. The Quantum Group to Present at the Jesup & Lamont Emerging Growth Stock Conference on February 28th
2. The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007
3. The Quantum Group, Inc. Announces Separation of Units
4. Results promising for computational quantum chemical methods for drug development
5. The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol QGP
6. American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.
7. Quantum Foundation Makes a Half Million Dollars Available to Federally Qualified Health Centers
8. Quantum light beams good for fast technology
9. The Ensign Group Establishes $50 Million Credit Facility with GE Healthcare Financial Services
10. Vital Health Technologies, Inc. / Caribbean American Health Resorts Inc. Acquires Momentum Medical Group, Inc.
11. Justice Department Requires Divestiture in UnitedHealth Groups Acquisition of Sierra Health Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...edicine is in a precipitous decline, David C. Dale...hysicians (ACP), today joined with leading repres...ll for comprehensive reforms to attract, recruit a...e physicians. , During a panel discussion of th...Dale and other panelists spoke about the challenge...
(Date:5/16/2008)...wswire/- "Huh, what did you,say?" is a phrase bein...hildren. More than 30 million Americans, that is 1...nd the numbers are growing at a dramatic rate.,Thi...me form of hearing,loss. An effort to bring more a...at led Kathlyn Maguire, who has profound hearing l...
(Date:5/16/2008)...Million for Life-threatening,Disease, BETHESDA, M...early,every state will raise funds for cystic fibr...ting in GREAT STRIDES, the largest national CF,fun... today., May is National Cystic Fibrosis Awarenes...etic disease that causes fatal lung infections and...
(Date:5/16/2008)...10,000 Sensual O Condom Packs Donation Marks the ... LOS ANGELES, May 16 /PRNewswire/ -- On Saturday, ...wn best for his hit song "Everybody in the Club,Ge...Institute (UHI) with,10,000 Sensual O Vibrating Co...ng made to promote the launch of the Association f...
Breaking Medicine News(10 mins):Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 3Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:Everybody in the Club Scream O! 2
...eghalaya so far this year, state Health minister E... to a calling attention notice, Marak said 11 deat...South Garo, six from East Garo Hills, nine died in...hasi and Ri-Bhoi district reported three deaths. T...
...r C. Divakaran Wednesday confirmed that pig fever ...igs at a private farminwayanad//. This is believed...he country. "Pig fever was ascribed to the death ...inary Research Institute in Uttar Pradesh after sa...
...ause heat is capable of relieving pain, say resear... use of DNA technology//, scientists were able to ...ells. When the heat is on, it has a pain relievin...s of heat for pain relief on par with a pain kille...
...exander Downer has sanctioned $17 million to take ...on of HIV-AIDS//, tuberculosis and malaria. To quo...re than half a million people to be treated with a...an $1.4 million people to be treated for tuberculo...
Other Medicine News:
(Date:5/16/2008)...s Potential Biomarkers -- for Lung Cancer Diagnosi...With Cancer of Unknown Primary ...fy Cancer Types With High Sensitivity and, Speci...ment of Cancer Results of microRNA Signature to I...racy Exceeding 90% and Specificity of 99%, REHOVO...
(Date:5/15/2008)...KE, N.J., May 15 /- Eisai Corporation...m 16 clinical data abstracts about,compounds in th...nd,preclinical oncology research have been accepte...he American Society of Clinical Oncology (ASCO),t...., A wide variety of abstracts on Eisai marketed ...
(Date:5/15/2008)...Presented at ASCO Showed Acceptable Tolerability P...and 4 Neuropathy, WOODCLIFF LAKE, N.J., May 15 /P... agent eribulin mesylate (E7389) demonstrated acti...ith locally advanced or metastatic,breast cancer, ...inical,trial. The study also suggests that eribuli...
(Date:5/15/2008)... N.J., May 15 /- Sanofi-ave... that findings from the,landmark ATHENA study show...r the treatment of patients with atrial fibrillati...vascular hospitalizations or death from any,cause ... meeting the study,primary endpoint. The ATHENA re...
Breaking Medicine Technology:Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 4Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 5Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 2Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 4Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 7Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 8Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7Anxiety linked to newly diagnosed DCIS patients overestimation of breast cancer risks 11720 1Anxiety linked to newly diagnosed DCIS patients overestimation of breast cancer risks 11720 2Precancerous Breast Lesions Cause Unnecessary Worry 11716 1Precancerous Breast Lesions Cause Unnecessary Worry 11716 2Precancerous Breast Lesions Cause Unnecessary Worry 11716 3Precancerous Breast Lesions Cause Unnecessary Worry 11716 4Kaiser Permanente Approves 2429 Million in Community Benefit Grants 11713 1Kaiser Permanente Approves 2429 Million in Community Benefit Grants 11713 2Kaiser Permanente Approves 2429 Million in Community Benefit Grants 11713 3Northwestern Memorial HealthCare and Northwestern Memorial Foundation Elect New Members to Board of Directors 11709 1Northwestern Memorial HealthCare and Northwestern Memorial Foundation Elect New Members to Board of Directors 11709 2
Hydrophilic Acrylic Intraocular Lens (Refractive and Bifocal). Anterior Chamber Lens.
...ade; hydrophilic acrylic IOL is the newest advance...e patient and surgeon in mind. Its unique one-piec...rosslinked with PMMA haptics to provide superb con...e and biocompatibility. The high memory lathe-cut ...
FZ60 : the 1st monobloc hard & soft IOL. Thanks to an exclusive and patented process : the selective polymerisation, IOLTECH designed the first single piece rigid & soft IOL : the FZ60. This technolo
TRIPODE Hydrophilic Acrylic Lens.
Medicine Products: